 LAS VEGAS, NV ACCESSWIRE March 31, 2021 CLS Holdings USA, Inc. OTCQB:CLSH CSE:CLSH, the Company or CLS, a diversified cannabis company operating as Cannabis Life Sciences, today announced that following receipt of the requisite approval of debentureholders and the Canadian Securities Exchange, it has amended the terms of its outstanding US13,500,150 principal amount unsecured convertible debentures the December Debentures issued December 12, 2018 by, among other things, i reducing the conversion price from US0.80 per unit to US0.30 per unit; ii extending the maturity date of the December Debentures from December 12, 2021 to December 12, 2022; and iii reducing the mandatory conversion VWAP threshold from US1.20 to US0.60 per share of common stock. The exercise price of the warrants issuable upon conversion of the December Debentures was also reduced to US0.40 from US1.10 per share of common stock in connection with the amendments to the December Debentures. 